Dipeptidyl peptidase II is not a marker for progression in melanoma

Journal of Dermatological Science

Volumn 53, Issue 1, 2009, Pages 68-71

  Fröhlich, Eleonore ^a   Maier, Elke ^a   Mack, Andreas F ^a   Garbe, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cathepsin B; Dipeptidylpeptidase 7; Dipeptidylpeptidase II; Melanoma; Nevus

Indexed keywords

BIOLOGICAL MARKER; DIPEPTIDYL PEPTIDASE II; MESSENGER RNA; SERINE PROTEINASE; UNCLASSIFIED DRUG;

DISEASE ACTIVITY; ENZYME ACTIVITY; IMMUNOREACTIVITY; LETTER; MELANOMA; NEVUS CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TUMOR GROWTH;

DIPEPTIDYL PEPTIDASES; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MELANOMA; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 57549114690     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2008.07.014     Document Type: Letter

References (10)

1. Maes M.B., Lambeir A.M., Gilany K., et al. Kinetic investigation of human dipeptidyl peptidase II (DPPII)-mediated hydrolysis of dipeptide derivatives and its identification as quiescent cell proline dipeptidase (QPP)/dipeptidyl peptidase 7 (DPP7). Biochem J 386 (2005) 315-324
2. McDonald J.K., and Schwabe C. Dipeptidyl peptidase II of bovine dental pulp. Initial demonstration and characterization as a fibroblastic, lysosomal peptidase of the serine class active on collagen-related peptides. Biochim Biophys Acta 616 (1980) 68-81
3. Klener P., Lojda Z., Haber J., and Kvasnicka J. Possible prognostic significance of the assessment of dipeptidylpeptidase II in peripheral blood lymphocytes of patients with chronic lymphocytic leukemia. Neoplasma 34 (1987) 581-586
4. Komatsu M., Urade M., Yamaoka M., Fukasawa K., and Harada M. Alteration in dipeptidyl peptidase activities in cultured human carcinoma cells. J Natl Cancer Inst 78 (1987) 863-868
5. Krepela E., Prochazka J., Mynarikova H., Karova B., Cermak J., and Roubkova H. Lysosomal dipeptidyl-peptidases I and II in human squamous cell lung carcinoma and lung parenchyma. Neoplasma 43 (1996) 171-178
6. Schlagenhauff B., Klessen C., Teichmann-Dörr S., Breuninger H., and Rassner G. Demonstration of proteases in basal cell carcinomas: a histochemical study using amino acid-4-methoxy-2-naphthyl-amides as chromogenic substrates. Cancer 70 (1992) 1133-1140
7. Khin E.E., Kikkawa F., Ino K., et al. Dipeptidyl peptidase IV expression in endometrial endometrioid adenocarcinoma and its inverse correlation with tumor grade. Am J Obstet Gynecol 188 (2003) 670-676
8. Tokuhara T., Adachi M., Hashida H., et al. Neutral endopeptidase/CD10 and aminopeptidase N/CD13 gene expression as a prognostic factor in non-small cell lung cancer. Jpn J Thorac Cardiovasc Surg 49 (2001) 489-496
9. Araki H., Li Y., Yamamoto Y., et al. Purification, molecular cloning, and immunohistochemical localization of dipeptidyl peptidase II from the rat kidney and its identity with quiescent cell proline dipeptidase. J Biochem (Tokyo) 129 (2001) 279-288
10. Kehlen A., Lendeckel U., Dralle H., Langner J., and Hoang-Vu C. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas. Cancer Res 63 (2003) 8500-8506